Citigroup’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$414K Sell
12,726
-877
-6% -$28.8K ﹤0.01% 3654
2025
Q4
$432K Buy
13,603
+7,088
+109% +$213K ﹤0.01% 3642
2025
Q3
$153K Sell
6,515
-19,715
-75% -$338K ﹤0.01% 4101
2025
Q2
$298K Sell
26,230
-48,390
-65% -$459K ﹤0.01% 3881
2025
Q1
$496K Buy
74,620
+16,487
+28% +$154K ﹤0.01% 3683
2024
Q4
$641K Buy
58,133
+32,467
+126% +$399K ﹤0.01% 3653
2024
Q3
$315K Buy
25,666
+10,522
+69% +$149K ﹤0.01% 4043
2024
Q2
$205K Buy
15,144
+9,678
+177% +$131K ﹤0.01% 3859
2024
Q1
$73.8K Buy
5,466
+1,494
+38% +$9.05K ﹤0.01% 4432
2023
Q4
$20.9K Buy
3,972
+3,372
+562% +$14.4K ﹤0.01% 4974
2023
Q3
$2.36K Sell
600
-8,868
-94% -$58.3K ﹤0.01% 4917
2023
Q2
$101K Buy
9,468
+8,623
+1,020% +$91.7K ﹤0.01% 4246
2023
Q1
$7.04K Sell
845
-197
-19% -$1.78K ﹤0.01% 4853
2022
Q4
$9.62K Sell
1,042
-152
-13% -$1.58K ﹤0.01% 4852
2022
Q3
$15K Sell
1,194
-1,434
-55% -$22.9K ﹤0.01% 4854
2022
Q2
$35K Sell
2,628
-17,932
-87% -$272K ﹤0.01% 4697
2022
Q1
$433K Sell
20,560
-34,234
-62% -$686K ﹤0.01% 3610
2021
Q4
$1.31M Buy
54,794
+14,927
+37% +$356K ﹤0.01% 2977
2021
Q3
$1.01M Sell
39,867
-28,749
-42% -$802K ﹤0.01% 3074
2021
Q2
$2.31M Buy
68,616
+24,679
+56% +$872K ﹤0.01% 2559
2021
Q1
$1.71M Buy
43,937
+40,015
+1,020% +$2.28M ﹤0.01% 2601
2020
Q4
$243K Buy
3,922
+1,076
+38% +$49.3K ﹤0.01% 4846
2020
Q3
$95K Sell
2,846
-2,900
-50% -$82.8K ﹤0.01% 5163
2020
Q2
$137K Sell
5,746
-1,446
-20% -$34.3K ﹤0.01% 5311
2020
Q1
$165K Buy
7,192
+2,800
+64% +$69.2K ﹤0.01% 4900
2019
Q4
$124K Buy
4,392
+3,985
+979% +$100K ﹤0.01% 5569
2019
Q3
$9K Buy
+407
New +$11.3K ﹤0.01% 7138

Other funds holding STOK